Article info

Original research
Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch

Authors

  1. Correspondence to Dr S Nierkens; S.Nierkens-2{at}prinsesmaximacentrum.nl
View Full Text

Citation

Cornel AM, Dunnebach E, Hofman DA, et al
Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch

Publication history

  • Accepted September 22, 2022
  • First published December 15, 2022.
Online issue publication 
October 18, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.